【レポートの概要(一部)】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
• Drug profiles
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Clinical application
• Treatment guidelines
• Key buying criteria
PART 05: Hypercholesterolemia: An overview
• History of hypercholesterolemia
• Hypercholesterolemia management market dynamics
• Hypercholesterolemia prescription landscape
• Management of hypercholesterolemia
• Epidemiology
• Unmet medical needs and role of PCSK9 and CETP inhibitors
PART 06: Pipeline portfolio
• Information on pipeline candidates
PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 08: segmentation by type of disease
• FH
• Non-FH
PART 09: Market segmentation by MOA
• HMG-CoA reductase inhibitors
• Fibric acid derivatives
• Nicotinic acid
• Bile acid sequestrants
• Other
PART 10: Market segmentation by drug class
• Statins
• Non-statins
PART 11: Geographical segmentation
• Global hypercholesterolemia drugs market by geographical segmentation 2015-2020
• Hypercholesterolemia drugs market in Americas
• Hypercholesterolemia drugs market in EMEA
• Hypercholesterolemia drugs market in APAC
PART 12: Market drivers
• Increasing risk of CVDs
• Rising prevalence of chronic diseases
• Promising pipeline of drugs
• Change in ATP guidelines for management of hypercholesterolemia
• Growing older population
PART 13: Impact of drivers
PART 14: Market challenges
• Loss of patent exclusivity of branded therapies
• Drawbacks associated with current therapies
• High cost of therapy
• Stringent regulatory guidelines
• Lack of proper diagnosis
PART 15: Impact of drivers and challenges
PART 16: Market trends
• Expected entry of cost-effective OTC versions
• Increasing use of statins
• Increased use of combination therapies
• Consideration of lifestyle management in ATP guidelines
PART 17: Vendor landscape
• Competitive scenario
• Market share analysis 2015
PART 18: Key vendor analysis
• AbbVie
• Aegerion Pharmaceuticals
• AstraZeneca
• Merck
• Pfizer
• Sanofi
• Other prominent vendors
PART 19: Appendix
• List of abbreviations
PART 20: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Different class of lipoproteins
Exhibit 03: Evaluation of lipoprotein levels based on ATP III classification
Exhibit 04: Key buying criteria for hypercholesterolemia drugs
Exhibit 05: Timeline of cholesterol lowering drugs
Exhibit 06: Market dynamics for hypercholesterolemia
Exhibit 07: Prescription landscape for statins 2015
Exhibit 08: Prescription landscape for ezetimibe 2015
Exhibit 09: Prescription landscape for other classes 2015
Exhibit 10: Distribution of cholesterol-lowering medication for individuals above 40 years
Exhibit 11: Percentage use of prescription cholesterol-lowering medication in US for various indications 2015
Exhibit 12: Treatment of hypercholesterolemia
Exhibit 13: Pharmacological treatment of hypercholesterolemia
Exhibit 14: High cholesterol levels by race and ethnicity in US 2015
Exhibit 15: PCSK9 inhibitors in preclinical and clinical development 2015
Exhibit 16: Pipeline portfolio: Global hypercholesterolemia drugs market
Exhibit 17: Pipeline share of hypercholesterolemia drugs
Exhibit 18: Global hypercholesterolemia drugs market 2015-2020 ($ billions)
Exhibit 19: Five forces analysis
Exhibit 20: Classification of hyperlipidemia
Exhibit 21: Global hypercholesterolemia market segmentation by MOA
Exhibit 22: Global hypercholesterolemia market segmentation by MoA 2015
Exhibit 23: Global hypercholesterolemia drugs market segmentation by drug class
Exhibit 24: Global hypercholesterolemia drugs market by drug class 2015 (% share)
Exhibit 25: Hypercholesterolemia drugs market revenue by drug class 2015-2020 ($ billions)
Exhibit 26: Global statin market 2015-2020 ($ billions)
Exhibit 27: Number of prescriptions for statins in US
Exhibit 28: Usage of statins for hypercholesterolemia in US 2015
Exhibit 29: Usage of statins for hypercholesterolemia in UK 2015
Exhibit 30: Global non-statins market 2015-2020 ($ billions)
Exhibit 31: Number of prescriptions for non-statins in US
Exhibit 32: Global hypercholesterolemia drugs market: YoY growth and revenue based on drug class 2015-2020
Exhibit 33: Segmentation of global hypercholesterolemia drugs markets by geography 2015
Exhibit 34: Hypercholesterolemia drugs market revenue by geography 2015-2020 ($ billions)
Exhibit 35: Percentage share of hypercholesterolemia drugs market by geography 2015-2020 (%)
Exhibit 36: Hypercholesterolemia drugs market in Americas 2015-2020 ($ billions)
Exhibit 37: Share of hypercholesterolemia drugs market in Americas by country 2015
Exhibit 38: Hypercholesterolemia drugs market in EMEA 2015-2020 ($ billions)
Exhibit 39: Hypercholesterolemia drugs market in APAC 2015-2020 ($ billions)
Exhibit 40: Global hypercholesterolemia drugs market: YoY growth and revenue based on geography 2015-2020
Exhibit 41: Population aged 60 years and over: World, developed and developing regions ($ millions)
Exhibit 42: Impact of drivers
Exhibit 43: Impact of drivers and challenges
Exhibit 44: Arguments for and against OTC switch by pharmaceutical companies and regulatory organizations
Exhibit 45: Market share analysis of global hypercholesterolemia drugs market 2015
Exhibit 46: Revenue from the sales of top five products in hypercholesterolemia drugs market 2013-2015 ($ billions)
Exhibit 47: AbbVie: YoY revenue and growth rate of lipid franchise portfolio 2013-2015 ($ millions)
Exhibit 48: Key takeaways
Exhibit 49: Aegerion: YoY revenue and growth rate of JUXTAPID 2013-2015 ($ millions)
Exhibit 50: Key takeaways
Exhibit 51: AstraZeneca: YoY revenue and growth rate of Crestor 2013-2015 ($ billions)
Exhibit 52: AstraZeneca: Geographic segmentation of Crestor 2015 by revenue
Exhibit 53: Key takeaways
Exhibit 54: Merck: YoY revenue and growth rate of Zetia 2013-2015 ($ billions)
Exhibit 55: Merck: YoY revenue and growth rate of Vytorin 2013-2015 ($ billions)
Exhibit 56: Merck: YoY revenue and growth rate of Zocor 2013-2015 ($ millions)
Exhibit 57: Merck: Key takeaways
Exhibit 58: Pfizer: YoY revenue and growth rate of Lipitor 2013-2015 ($ billions)
Exhibit 59: Pfizer: Geographic segmentation of Lipitor by revenue 2015
Exhibit 60: Pfizer: YoY revenue and growth rate of Caduet 2012-2014 ($ millions)
Exhibit 61: Key takeaways
Exhibit 62: Sanofi: Key takeaways
【レポート販売概要】
■ タイトル:高コレステロール血症治療薬の世界市場2016-2020■ 英文:Global Hypercholesterolemia Drugs Market 2016-2020
■ 発行日:2016年7月25日
■ 調査会社:Technavio
■ 商品コード:IRTNTR9069
■ 調査対象地域:グローバル
- 世界のスキンケア市場動向(2014年4月):ニュース・イベントSynopsis Using this report, marketers will effectively gain an insight into the latest happenings in the global skincare market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global skincare market on a monthly basis. Scope The report provides a review of the latest news and key events in the global skin …
- ブレーキ装置の世界市場:用途(乗用車、商用車、オフハイウェイ車両、ワゴン、機関車、RTV)、種類(ディスクブレーキ、ドラムブレーキ)、技術(ABS、TCS、ESC、EBD)Asia-Oceania is estimated to dominate the brake system market for automotive. The growth can be majorly attributed to the increasing demand of vehicles across the region. As of 2015, China and Japan are estimated to lead the brake system market for automotive in the region, whereas the Indian brake system market for automotive is projected to be one of the fastest growing markets. This growth can …
- dL-イソクエン酸ラクトンの世界市場DL-Isocitric Acid Lactone (CAS 4702-32-3) Market Research Report 2013 presents comprehensive data on dl-isocitric acid lactone markets globally and regionally (Europe, Asia, North America etc.) The DL-Isocitric Acid Lactone (CAS 4702-32-3) Market Research Report 2013 includes dl-isocitric acid lactone description, covers its application areas and related patterns. It overviews dl-isocitric acid la …
- 世界の掘削機市場(2014-2018)About Excavator Market The The Global Construction Equipment market has experienced several pitfalls in the past decade due to the global economic recession. Excavators form an integral part of the Global Construction Equipment market; therefore, they experienced a decrease in their demand during the recession. There are two types of excavators: mini/midi excavators and crawler/wheeled excavators. …
- テクニカルテキスタイルの世界市場2016-2020About Technical Textiles Technical textiles are textiles that are manufactured and used for their functionality rather than their aesthetic value. Technical textiles are designed for providing conductivity, filtration, flexibility, lightness, reinforcement, resistance, strength, and others. Technical textiles are used in automotive, construction, sport and leisure, and water treatment industries. …
- インターベンショナル心臓および末梢血管用医療デバイスの世界市場:塞栓保護デバイス、慢性完全閉塞、粥腫切除術、血栓摘出術、IVUS、血管造影用カテーテル、EVARステントグラフト、下大静脈フィルター、ステント、血管形成術用バルーンThe interventional cardiology and peripheral vascular devices market is expected to reach $26.72 billion by 2019 from $18.73 billion in 2014, at a CAGR of 7.4%. The global interventional cardiology and peripheral vascular devices market is segmented based on products and geography. Based on products, the market is segmented into angioplasty balloons, angioplasty stents, catheters, EVAR stent graft …
- 自動車用センサの世界市場2016-2020About Automotive Sensors A sensor is a device that detects changes in its immediate environment by picking stimulus changes and updates the system electronically. Sensors are engineered to detect chemical, physical, and process changes. A sensor sends out electronic signals, which are measured and recorded, and based on the information a corrective change is executed. There are many types of autom …
- モーターコントロールセンター(MCC)の世界市場動向・予測(~2021)The global motor control centers market is projected to grow at a CAGR of 5.3% from 2016 to 2021, to reach a size of USD 5.83 Billion by 2021. This growth is attributed to increasing demand for industrial automation and growing concerns for energy efficiency across major industries. On the basis of end-user industry, the report segments motor control centers market into commercial and industrial. …
- VSaaS(映像監視クラウドサービス)の世界市場2017-2021About Video Surveillance as A ServiceVideo surveillance is the process of monitoring or observing the activities, behavior, or movements of an individual or a group to provide enhanced security. It is used by retail stores, government departments, hospitals, transportation and logistics companies, and law enforcement agencies to prevent criminal activities. Integration of the video surveillance so …
- 電気手術の世界市場予測(~2021):製品別(発電機、器具-バイポーラ(ベッセルシーリング、鉗子)&モノポーラ(ペンシル、電極)、アクセサリ、アルゴン&排煙管理システム)、手術種類別The electrosurgery market is expected to reach USD 5.17 Billion by 2021 from USD 4.27 Billion in 2016, at a CAGR of 3.9% between 2016 and 2021. Factors such as technological advancements in electrosurgery devices, growing number of medical, aesthetic and plastic surgeries, rising demand for minimally invasive surgeries, and growing number of ambulatory surgery centers are driving the growth of thi …
- MarkWest Energy Partners, L.P.:石油・ガスバリューチェーン分析レポート2013MarkWest Energy Partners, L.P. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "MarkWest Energy Partners, L.P." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “MarkWest Energy Partners, L.P.”. The report provides key information relating to oil and gas assets of the company along with its operations across th …
- Solar Photovoltaic (PV), 2012 – Global Market Size, Market Share, Average Price, Regulations and Key Country Analysis to 2020Solar Photovoltaic (PV), 2012 - Global Market Size, Market Share, Average Price, Regulations and Key Country Analysis to 2020 Summary “Solar Photovoltaic (PV), 2012 - Global Market Size, Market Share, Average Price, Regulations and Key Country Analysis to 2020” is the latest report from industry analysis specialist GlobalData, offering comprehensive information on and analysis of the global solar …
- 電力ケーブル付属品の世界市場About the Cable Accessories Market Cable accessories form an integral part of power cable systems; these are essential components in the power cables used in the transmission and distribution of electricity, from the point of generation to the point of consumption. Depending on the operating voltage level, power cables can be categorized as low voltage (below 1 kV), medium voltage (1 kV to 33 kV), …
- 世界のスマートグリッド向けサイバーセキュリティ市場(2014-2018)About Smart Grid Cyber Security Smart grid cyber security involves the protection of smart grid technology from various cyber threats. The security of the smart grid network is a major issue faced by power utilities because there is a frequent exchange of sensitive information via communication networks such as the internet, intranets, corporate networks, and extranets. Power utilities need variou …
- UK HIV/AIDS Diagnostics Market 2014: Hospitals, Blood Banks, Public Health Labs, Commercial Labs–Supplier Shares and Sales Forecasts For Immunodiagnostic and NAT ProceduresComplete report $2,300. DataPack (test volumes, sales forecasts, supplier shares) $1,500.Summary This report presents detailed analyses of the AIDS diagnostics market in the UK. The report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following market segments: - Hospitals   …